Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
J Clin Pharm Ther. 2010 Feb;35(1):87-92. doi: 10.1111/j.1365-2710.2009.01074.x.
We aimed to investigate recent trends in prescriptions for the treatment of paediatric gastroenteritis in Japan over a 10-year period (1997-2007).
In this retrospective cohort study, we collected data for 2295 prescriptions for 1241 putative cases of paediatric gastroenteritis, which were treated between 1997 and 2007 at Hamamatsu University Hospital, Hamamatsu, Japan.
The most frequently prescribed drugs were probiotics (n = 621), followed by anti-emetics (n = 474). In most years between 1997 and 2007, more cases were treated with probiotics than with any other drug type (30.6-63.3% of cases), with the percentage increasing between 2005 and 2007. In contrast, the frequencies of anti-emetic and antipyretic prescriptions remained fairly stable, and prescriptions for antibiotics decreased slightly over the study period. Anti-emetics were commonly used in this hospital.
Although experimental evidence upon which to base recommendations is lacking, Japanese evidence-based guidelines are critical for improving the quality of treatment of paediatric gastroenteritis.
我们旨在调查日本近 10 年来(1997-2007 年)治疗小儿肠炎的处方趋势。
在这项回顾性队列研究中,我们收集了日本滨松大学医院 1997 年至 2007 年间治疗的 1241 例疑似小儿肠炎的 2295 份处方的数据。
最常开的药物是益生菌(n = 621),其次是止吐药(n = 474)。在 1997 年至 2007 年的大多数年份中,使用益生菌治疗的病例多于任何其他药物类型(30.6-63.3%的病例),2005 年至 2007 年期间这一比例有所增加。相比之下,止吐药和退烧药的处方频率相对稳定,抗生素的处方数量在研究期间略有下降。止吐药在这家医院中经常使用。
尽管缺乏基于实验证据的推荐依据,但日本的循证指南对于改善小儿肠炎的治疗质量至关重要。